This inventor holds 1 USPTO granted patent. Top assignee: Wyeth. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Annabel L Olsen Hedemyr: Innovator in Pharmaceutical Chemistry
Introduction
Annabel L Olsen Hedemyr, based in Stockholm, Sweden, stands out as a dedicated inventor with a focus on pharmaceutical chemistry. Her innovative approach has led to the development of novel compounds that have significant potential in the treatment of various diseases.
Latest Patents
Annabel holds one patent which centers around Indazoles. This invention provides compounds of Formula (I) or (Ia), which are instrumental in the treatment or inhibition of diseases mediated by Liver X Receptors (LXR). The implications of her work are promising, contributing to advancements in the medical field.
Career Highlights
Annabel is associated with Wyeth, a well-known pharmaceutical company. Throughout her career, she has demonstrated an unwavering commitment to research and development, making substantial contributions to the field of drug discovery and innovation.
Collaborations
In her journey, Annabel has collaborated with esteemed colleagues, including Robert J Steffan and Edward Martin Matelan. These partnerships have enabled her to enhance her research capabilities and drive forward the development of her innovative solutions in the pharmaceutical arena.
Conclusion
Annabel L Olsen Hedemyr is a remarkable inventor whose contributions to pharmacology and innovation are noteworthy. Her work continues to inspire advancements in treatment methodologies, illustrating the vital role that inventors play in improving healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile